Title : Pentoxifylline for the treatment of nonalcoholic fatty liver disease: a meta-analysis of randomized double-blind, placebo-controlled studies.

Pub. Date : 2014 Jun

PMID : 24743504






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 AIMS: Pentoxifylline has been used to treat nonalcoholic fatty liver diseases (NAFLDs) due to its anti-tumor necrosis factor-alpha effects. Pentoxifylline tumor necrosis factor Homo sapiens
2 Furthermore, pentoxifylline also led to significant reduction in BMI (WMD=-0.51; 95% CI: -0.96, -0.06) and fasting glucose (WMD=-8.97; 95% CI: -14.52, -3.42), but did not significantly affect the serum tumor necrosis factor alpha and adiponectin levels when compared with placebo. Pentoxifylline tumor necrosis factor Homo sapiens